150 related articles for article (PubMed ID: 24528787)
1. Enhanced detection of metastatic prostate cancer cells in human plasma with lipid bodies staining.
Mitra R; Goodman OB; Le TT
BMC Cancer; 2014 Feb; 14():91. PubMed ID: 24528787
[TBL] [Abstract][Full Text] [Related]
2. Detection of lipid-rich prostate circulating tumour cells with coherent anti-Stokes Raman scattering microscopy.
Mitra R; Chao O; Urasaki Y; Goodman OB; Le TT
BMC Cancer; 2012 Nov; 12():540. PubMed ID: 23171028
[TBL] [Abstract][Full Text] [Related]
3. Enrichment and mutation detection of circulating tumor cells from blood samples.
Kou R; Zhao J; Gogoi P; Carskadon S; Chow W; Hwang C; Palanisamy N; Leung C; Wang Y
Oncol Rep; 2018 Jun; 39(6):2537-2544. PubMed ID: 29620284
[TBL] [Abstract][Full Text] [Related]
4. [In vitro detection of prostate cancer circulating cells by immunocytochemistry, flow cytometry and RT-PCR PSA].
de la Taille A; Muscatelli B; Colombel M; Jouault H; Amsellem S; Mazeman E; Abbou CC; Chopin D
Prog Urol; 1998 Dec; 8(6):1058-64. PubMed ID: 9894270
[TBL] [Abstract][Full Text] [Related]
5. Androgen Receptor and Its Splicing Variant 7 Expression in Peripheral Blood Mononuclear Cells and in Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer.
Marín-Aguilera M; Jiménez N; Reig Ò; Montalbo R; Verma AK; Castellano G; Mengual L; Victoria I; Pereira MV; Milà-Guasch M; García-Recio S; Benítez-Ribas D; Cabezón R; González A; Juan M; Prat A; Mellado B
Cells; 2020 Jan; 9(1):. PubMed ID: 31947623
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands.
He W; Kularatne SA; Kalli KR; Prendergast FG; Amato RJ; Klee GG; Hartmann LC; Low PS
Int J Cancer; 2008 Oct; 123(8):1968-73. PubMed ID: 18661519
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric detection of prostate tumor cells using chemoaffinity labels.
Wu LY; Liu T; Grimm AL; Davis WC; Berkman CE
Prostate; 2011 Jan; 71(1):52-61. PubMed ID: 20632319
[TBL] [Abstract][Full Text] [Related]
8. Chemoaffinity capture of pre-targeted prostate cancer cells with magnetic beads.
Wu LY; Liu T; Hopkins MR; Davis WC; Berkman CE
Prostate; 2012 Oct; 72(14):1532-41. PubMed ID: 22488169
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis of circulating tumor cells in prostate cancer patients.
Larson CJ; Moreno JG; Pienta KJ; Gross S; Repollet M; O'hara SM; Russell T; Terstappen LW
Cytometry A; 2004 Nov; 62(1):46-53. PubMed ID: 15472900
[TBL] [Abstract][Full Text] [Related]
10. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
Kim J; Roh M; Abdulkadir SA
BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470
[TBL] [Abstract][Full Text] [Related]
11. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
[TBL] [Abstract][Full Text] [Related]
12. IL-4 Counteracts the Cytotoxic Effects of Peripheral Blood Mononuclear Cells on Hormone-sensitive Prostate Cancer Cells.
Erb HHH; Culig Z; Stope MB
In Vivo; 2021; 35(4):1973-1977. PubMed ID: 34182471
[TBL] [Abstract][Full Text] [Related]
13. Do androgen deprivation drugs affect the immune cross-talk between mononuclear and prostate cancer cells?
Salman H; Bergman M; Blumberger N; Djaldetti M; Bessler H
Biomed Pharmacother; 2014 Feb; 68(1):21-4. PubMed ID: 24406295
[TBL] [Abstract][Full Text] [Related]
14. Human prostate fibroblasts induce growth and confer castration resistance and metastatic potential in LNCaP Cells.
Thalmann GN; Rhee H; Sikes RA; Pathak S; Multani A; Zhau HE; Marshall FF; Chung LW
Eur Urol; 2010 Jul; 58(1):162-71. PubMed ID: 19747763
[TBL] [Abstract][Full Text] [Related]
15. 177Lu-AMBA biodistribution, radiotherapeutic efficacy, imaging, and autoradiography in prostate cancer models with low GRP-R expression.
Maddalena ME; Fox J; Chen J; Feng W; Cagnolini A; Linder KE; Tweedle MF; Nunn AD; Lantry LE
J Nucl Med; 2009 Dec; 50(12):2017-24. PubMed ID: 19910427
[TBL] [Abstract][Full Text] [Related]
16. Human prostate cancer cells induce inflammatory cytokine secretion by peripheral blood mononuclear cells.
Salman H; Ori Y; Bergman M; Djaldetti M; Bessler H
Biomed Pharmacother; 2012 Jul; 66(5):330-3. PubMed ID: 22739042
[TBL] [Abstract][Full Text] [Related]
17. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR
BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561
[TBL] [Abstract][Full Text] [Related]
18. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
[TBL] [Abstract][Full Text] [Related]
19. Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer.
Chen CL; Mahalingam D; Osmulski P; Jadhav RR; Wang CM; Leach RJ; Chang TC; Weitman SD; Kumar AP; Sun L; Gaczynska ME; Thompson IM; Huang TH
Prostate; 2013 Jun; 73(8):813-26. PubMed ID: 23280481
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo.
Raffo AJ; Perlman H; Chen MW; Day ML; Streitman JS; Buttyan R
Cancer Res; 1995 Oct; 55(19):4438-45. PubMed ID: 7671257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]